# Synphatec funding rounds and investors

As of 13 Nov 2026, Synphatec has raised $50M across 1 verified round on record; latest: over $50 million Series A led by Decheng Capital, announced 28 Sep 2026.

CNS Innovative Drug Developer

Website: https://synphatec.com/  
Headquarters: Shanghai, China  
Page: https://fireround.dev/companies/synphatec

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-28 | Series A | over $50 million | Decheng Capital | China Merchants Venture, Huatai GenScript Fund, Morningside Group, Qianju Capital, Shunwei Capital | [flcube.com](https://flcube.com/synphatec-completes-over-usd-50-million-series-a-to-advance-cns-pipeline-rapid-acting-antidepressant-sp-101-and-alzheimers-gene-therapy-sp-201-enter-next-development-phase), [vcbeathealth.com](https://www.vcbeathealth.com/article/63348), [vcbeathealth.com](https://www.vcbeathealth.com/entity/312701) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.